Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$467.0K
6.19K shares
What this filing means
LIN ELIZABETH YEU plans to sell 6.19K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $467.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001959173-26-006670
Director
Since Dec 2021
6.19K
Shares to sell
$467.0K
Approx. market value
1.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
9/14/2022
1.59KTotal acquired1.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2022 | Open Market Purchase Cash | 1.59K | — |
| Total | 1.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.60K
Market value
$339.8K
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.59K
Market value
$127.2K
9/2/2026
Total
Units
6.19K
Value
$467.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 4.60K | $339.8K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 1.59K | $127.2K | NASDAQ | Planned |
| Total | 6.19K | $467.0K | ||